Globus Medical Inc - Ordinary Shares - Class A

Globus Medical Inc - Ordinary Shares - Class A

GMED - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$10.48B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Globus Medical Inc - Ordinary Shares - Class AGlobus Medical Inc - Ordinary Shares - Class A19.7-11%3.1-
$92.67

Target Price by Analysts

30.5% upsideGlobus Medical Target Price DetailsTarget Price
$229.79

Current Fair Value

223.5% upside

Undervalued by 223.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$10.48 Billion
Enterprise Value$10.12 Billion
Earnings per Share$3.98
Beta0.96
Outstanding Shares135,364,000

Return

Return on Equity11.23%ROE
Return on Assets9.76%
Return on Invested Capital13.01%

Valuation & Multiples

P/E Ratio19.66P/E Ratio
PEG-77.77PEG
Price to Sales3.09Price to Sales
Price to Book Ratio2.03Price to Book Ratio
Enterprise Value to Revenue3.22
Enterprise Value to EBIT15.53
Enterprise Value to Net Income18
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 5, 2026
EPS Estimate
$1.20
Consensus analyst estimate
Revenue Estimate
$792.39 M
Consensus analyst estimate

Next Earnings Call

Expected Date
February 23, 2027
EPS Estimate
$1.33
Consensus analyst estimate
Revenue Estimate
$857.73 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 19.40%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %7.09%▼ 81.72%
Total Invested$717.81M▼ 92.47%
Investors Holding190▼ 428.00%

About Globus Medical Inc

CEO: David Demski

Globus Medical Insider Information FAQ

Stockcircle tracks 7 top investors with a current 13F position in Globus Medical. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 5 top investors increased or opened positions and 4 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 3 open-market insider sales for Globus Medical in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 3 politician trade disclosures tied to Globus Medical in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Globus Medical in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.